MARKET

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ
2.820
+0.130
+4.83%
After Hours: 2.750 -0.07 -2.48% 16:05 03/14 EDT
OPEN
2.870
PREV CLOSE
2.690
HIGH
2.870
LOW
2.704
VOLUME
2.81K
TURNOVER
--
52 WEEK HIGH
15.70
52 WEEK LOW
2.414
MARKET CAP
3.40M
P/E (TTM)
-0.2018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INM last week (0303-0307)?
Weekly Report · 6d ago
Weekly Report: what happened at INM last week (0224-0228)?
Weekly Report · 03/03 12:33
Inmed Pharmaceuticals Inc. Reports Financial Results for the Quarter Ended December 31, 2024" or "Inmed Pharmaceuticals Inc. Files Quarterly Report with SEC for the Period Ended December 31, 2024
Press release · 03/03 05:00
Weekly Report: what happened at INM last week (0217-0221)?
Weekly Report · 02/24 12:33
Weekly Report: what happened at INM last week (0210-0214)?
Weekly Report · 02/17 12:29
InMed Pharmaceuticals Struggles with Losses Amid Revenue Decline
TipRanks · 02/15 04:04
InMed Pharmaceuticals Board Reshuffle After Director Resignation
TipRanks · 02/14 20:17
InMed Pharmaceuticals Reports Q2 2025 Financial Results
TipRanks · 02/13 14:58
More
About INM
InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

Webull offers InMed Pharmaceuticals Inc stock information, including NASDAQ: INM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INM stock methods without spending real money on the virtual paper trading platform.